Blueprint Medicines (BPMC) Announces Proposed $325M Public Offering of Shares of Common Stoc

Go back to Blueprint Medicines (BPMC) Announces Proposed $325M Public Offering of Shares of Common Stoc

Blueprint Medicines (BPMC) Prices 4.71M Share Common Offering at $69/Sh

January 23, 2020 5:53 AM EST

Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced the pricing of an underwritten public offering of 4,710,144 shares of its common stock at a public offering price of $69.00 per share, before underwriting... More